Synageva BioPharma to Present at the 31st Annual J.P. Morgan Healthcare Conference
LEXINGTON, Mass.--(BUSINESS WIRE)--Synageva BioPharma Corp. (“Synageva”) (NASDAQ:GEVA), a clinical stage biopharmaceutical company developing therapeutic products for rare disorders, announced today its presentation at the upcoming J.P. Morgan Healthcare conference being held in San Francisco, CA.